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Gallbladder Visualization on I-131 
Post-Ablative Whole Body Imaging Mimicking 
Hepatic Metastases 
Frank J. Welte, M.D., Robert H. Dann, M.D., James P. Polga, M.D., and 
Laurie E. Gianturco, M.D.
A 52-year-old woman with follicular thyroid carcinoma presented for ablative radioiodide and 
whole body I-131 imaging following subtotal thyroidectomy. An abnormal focus of increased 
activity was present in the region of the gallbladder fossa, persistent on delayed imaging. Subse-
quent CT revealed no hepatic metastases. Contemporaneously, the patient described right upper 
quadrant abdominal pain. Abdominal ultrasound demonstrated cholelithiasis. Cholecystectomy 
revealed extensive cholelithiasis and evidence of chronic cholecystitis; no hepatic metastases were 
identified. This case demonstrates the potential pitfall of gallbladder activity on I-131 whole body 
imaging secondary to cholecystitis mimicking hepatic metastases.
Cholecystitis is a relatively common condition and 
can rarely mimic hepatic metastases in patients under-
going post-ablative I-131 imaging for thyroid cancer. 
Introduction Additional clinical workup is necessary in these cases to 
distinguish between these possibilities.
A 52-year-old woman with follicular thyroid 
carcinoma presented for ablative radioiodide therapy 
(97.7 mCi Iodine-131; I-131) and whole body imag-
ing 8 weeks following subtotal thyroidectomy. Residual 
thyroid activity was noted, which is not atypical. An 
abnormal focus of increased activity was present in 
the region of the gallbladder fossa on 48 and 72 hour 
post-ablative imaging (Fig. 1). Initially, this activity was 
felt to likely represent activity within the bowel near the 
hepatic flexure, however delayed imaging at 11 days post 
ablation demonstrated persistent activity in this area 
(Fig. 2).
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Figure 1. 52-year-old woman with follicular thyroid carcinoma treated by subtotal thyroidectomy. Pre- (A, B) and Post-
ablative (C, D) whole body and spot I-131 imaging performed at 8 and 9 weeks status post subtotal thyroidectomy respec-
tively demonstrated residual activity in the thyroid bed (straight arrows in A-D). Post-ablative imaging (C, D) additionally 
demonstrated an intense focus of abnormal activity in the region of the gallbladder fossa (curved arrows in C, D), which was 
persistent on delayed imaging (see Fig. 2). Liver (arrowheads in C, D), bowel (dashed arrows in A-B), and bladder (tapered 
arrows in A-C) activity is also noted.
Iodine avid hepatic metastases, although somewhat 
unlikely given the normal appearing liver on recent 
ultrasound, could also give a similar appearance, al-
though a solitary hepatic metastasis of the size suggested 
by the nuclear imaging would be unusual. Due to the 
somewhat limited sensitivity of ultrasound for evalu-
ation of small lesions in the liver and the potential to 
significantly change management, an abdominal CT 
was performed to exclude hepatic metastases. Con-
sideration was given to the possibility that the patient 
may require additional radioiodine therapy and that a 
contrast enhanced CT may diminish the efficacy of such 
treatment. As the question to be addressed by the CT 
was of substantial clinical importance and would impact 
management and additional radioiodide therapy could 
potentially be administered in an only mildly delayed 
time frame, the clinical team and patient elected to 
proceed.
Contrast-enhanced abdominal CT performed 5 
weeks after ablative therapy revealed no hepatic metas-
tasis or other abnormalities in the liver. No inflamma-
tory changes were present in the hepatic flexure and the 
remainder of the bowel was also normal in appearance. 
Numerous calculi were noted in the gallbladder (Fig. 3). 
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Figure 2. Delayed spot I-131 imaging performed at 11 days post ablative therapy. Intense focal activity (curved arrows) 
remains visible in the region of the gallbladder fossa. The liver (arrowheads) shows lower level diffuse activity. Anterior (A) 
and posterior (B) views are shown.
Figure 3. Intravenous contrast-enhanced abdominal CT performed 3 weeks following ablative therapy and whole body imag-
ing demonstrated cholelithiasis (white arrowheads), but no evidence of hepatic metastases.
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Figure 3. Intravenous contrast-enhanced abdominal CT performed 3 weeks following ablative therapy and whole body imag-
ing demonstrated cholelithiasis (white arrowheads), but no evidence of hepatic metastases.
Discussion
This case demonstrates the potential pitfall of gall-
bladder activity on I-131 whole body imaging secondary 
to chronic cholecystitis mimicking hepatic metastases. 
Only two cases of gallbladder I-131 uptake after ablative 
therapy have been previously described in patients with 
chronic cholecystitis [1, 2]. Activity in the gallbladder 
and biliary tree on whole body I-131 scans has also in-
frequently been described in the context of biliary ductal 
dilatation [3], acute cholecystitis [4], and in the absence 
of any inflammatory or infectious processes involving 
the gallbladder [5, 6]. Numerous other causes of false 
positive results on whole body I-131 scans have also 
been described [7-11].
Review of the patient’s chart revealed that she had 
described right upper quadrant abdominal pain 7 weeks 
after thyroidectomy (5 days prior to ablative therapy). 
Abdominal ultrasound shortly thereafter also demon-
strated extensive cholelithiasis (Fig. 4). Laparoscopic 
converted to open cholecystectomy was subsequently 
performed 7 weeks after ablative therapy, where chole-
lithiasis and evidence of chronic cholecystitis were 
confirmed; no gross hepatic abnormalities were noted 
intra-operatively. At this point, the previously demon-
strated abnormal I-131 activity was attributed to gall-
bladder pathology. Chronic cholecystitis was confirmed 
on post-operative pathology.
Acute and chronic cholecystitis are relatively com-
mon conditions that can in rare instances be a source of 
false positive results in patients undergoing post-ablative 
whole body I-131 therapy. Additional clinical workup 
is necessary to distinguish between metastatic disease 
and various causes of false positives in these situations. 
Delayed I-131 imaging should be included to exclude 
bowel activity. Correlation with the patient’s history 
can also help determine if ultrasound or enhanced 
abdominal CT is warranted to determine the source of 
activity in the region of the gallbladder fossa. Even when 
cholecystitis is suspected to be responsible for this type 
of abnormal increased activity, contrast enhanced CT 
is often unavoidable to search for hepatic metastases as 
these entities may obviously coexist and the presence 
of metastatic disease would have significant clinical 
implications. 
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